Home › Compare › NBBTF vs MRK

NBBTF vs MRK: Dividend Comparison 2026

NBBTF yields 3389.83% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NBBTF wins by $1461359253692.36M in total portfolio value
10 years
NBBTF
NBBTF
● Live price
3389.83%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1461359253692.42M
Annual income
$1,381,206,507,162,207,700.00
Full NBBTF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — NBBTF vs MRK

📍 NBBTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNBBTFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NBBTF + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
NBBTF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NBBTF
Annual income on $10K today (after 15% tax)
$288,135.59/yr
After 10yr DRIP, annual income (after tax)
$1,174,025,531,087,876,600.00/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, NBBTF beats the other by $1,174,025,531,087,868,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NBBTF + MRK for your $10,000?

NBBTF: 50%MRK: 50%
100% MRK50/50100% NBBTF
Portfolio after 10yr
$730679626846.24M
Annual income
$690,603,253,581,109,000.00/yr
Blended yield
94.52%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

NBBTF
No analyst data
Altman Z
1.8
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NBBTF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNBBTFMRK
Forward yield3389.83% ✓2.81%
Annual dividend / share$2.00$3.32 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7% ✓
Portfolio after 10y$1461359253692.42M ✓$57.7K
Annual income after 10y$1,381,206,507,162,207,700.00 ✓$10,113.78
Total dividends collected$1455851640848.39M ✓$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NBBTF vs MRK ($10,000, DRIP)

YearNBBTF PortfolioNBBTF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$349,683$338,983.05$11,213$373.04+$338.5K → NBBTF
2$11,452,350$11,078,189.48$12,667$512.06+$11.44M → NBBTF
3$351,336,263$339,082,248.07$14,439$708.14+$351.32M → NBBTF
4$10,097,795,751$9,721,865,949.49$16,640$988.16+$10097.78M → NBBTF
5$271,942,269,608$261,137,628,154.11$19,432$1,394.07+$271942.25M → NBBTF
6$6,863,557,206,364$6,572,578,977,883.92$23,057$1,992.90+$6863557.18M → NBBTF
7$162,377,157,810,145$155,033,151,599,335.72$27,889$2,894.79+$162377157.78M → NBBTF
8$3,601,551,461,033,851$3,427,807,902,176,995.00$34,518$4,286.29+$3601551461.00M → NBBTF
9$74,909,108,906,737,280$71,055,448,843,431,064.00$43,912$6,494.35+$74909108906.69M → NBBTF
10$1,461,359,253,692,416,500$1,381,206,507,162,207,700.00$57,714$10,113.78+$1461359253692.36M → NBBTF

NBBTF vs MRK: Complete Analysis 2026

NBBTF — Stock

Natural Beauty Bio-Technology Limited, an investment holding company, offers skin care products and services in in the People's Republic of China, Taiwan, and internationally. The company manufactures and sells skin care, beauty, aroma-therapeutic, cosmetics, health supplements, and make-up products under the Natural Beauty brand. It also offers skin treatment, beauty and spa, medical cosmetology, skin care consulting, and beauty consulting and training services. In addition, the company's spas provide hydrotherapy, facial treatment, body care, and skin care analysis services. Further, it engages in the wholesale of skin care and beauty products. The company was founded in 1976 and is based in Wan Chai, Hong Kong.

Full NBBTF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this NBBTF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NBBTF vs SCHDNBBTF vs JEPINBBTF vs ONBBTF vs KONBBTF vs MAINNBBTF vs JNJNBBTF vs ABBVNBBTF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.